Developing a screen for new adjuvants to enhance RNA vaccines

Ended Project Grant Awarded Last action

Award ID
R21AI151824
Recipient
Awarding agency
Obligated
$511,601

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $436,697.17 Federal
  • $74,904.00 Non-federal
Place of performance
Seattle, WA 98102, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$15,043 $0
Amendment -$426 $0
Amendment -$426 -$426
Amendment $0 $0
Amendment $0 $0
Amendment $87,217 $0
Amendment $87,217 $87,217
Amendment -$11,887 $0
Amendment -$11,887 -$11,887
Original award $301,932 $0

Quick answers

Who received award R21AI151824?

R21AI151824 was awarded to PAI Life Sciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 12, 2020.

How much is award R21AI151824 worth?

$511,601 has been obligated on R21AI151824: $436,697 in federal funding and $74,904 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award